Market Overview - The Shanghai Composite Index rose by 1.38% on January 5, with 26 out of the 28 sectors experiencing gains, led by the media and pharmaceutical industries, which increased by 4.12% and 3.85% respectively [2] - The oil and petrochemical sector and the banking sector were the only ones to decline, with decreases of 1.29% and 0.34% respectively [2] Capital Flow Analysis - The net inflow of capital in the two markets was 8.334 billion yuan, with 15 sectors seeing net inflows [2] - The electronics sector had the highest net inflow, amounting to 9.481 billion yuan, with a daily increase of 3.69% [2] - The pharmaceutical sector also saw significant inflows, with a net inflow of 4.379 billion yuan and a daily increase of 3.85% [2] Pharmaceutical Industry Performance - The pharmaceutical sector rose by 3.85%, with a total of 450 out of 478 stocks in the sector increasing in value, including 22 stocks hitting the daily limit [3] - The top three stocks with the highest net inflow in the pharmaceutical sector were Lepu Medical, with a net inflow of 485 million yuan, followed by Zhongsheng Pharmaceutical and Innovation Medical, with inflows of 293 million yuan and 256 million yuan respectively [3] - The stocks with the highest net outflows included Changshan Pharmaceutical, with a net outflow of 103 million yuan, followed by Hefei China and Tonghua Golden Horse, with outflows of 77.36 million yuan and 75.85 million yuan respectively [5] Top Gainers in Pharmaceutical Sector - Notable gainers included Lepu Medical, which increased by 19.99% with a turnover rate of 9.07% and a capital flow of 484.8 million yuan [4] - Other significant gainers were Zhongsheng Pharmaceutical (up 10.01%, 29.26 million yuan) and Innovation Medical (up 10.00%, 25.64 million yuan) [4] Top Losers in Pharmaceutical Sector - The stocks with the largest losses included Changshan Pharmaceutical (down 1.00%, -102.55 million yuan), Hefei China (down 5.20%, -77.36 million yuan), and Tonghua Golden Horse (down 3.24%, -75.85 million yuan) [5]
医药生物行业资金流入榜:乐普医疗等15股净流入资金超亿元